The Costs of Diabetic Foot Ulcers
A diabetic foot ulcer (DFU) is a
devastating complication of diabetes that exacts a terrible cost on patients,
families, and society. Diabetic foot ulcers are more likely to occur in the
setting of associated diabetic complications of peripheral vascular disease and
peripheral neuropathy. These comorbidities also hinder the healing process,
leading to chronic non-healing wounds.
The treatment of these wounds is intense
and expensive. For recalcitrant wounds, amputation may be necessary. Amputation
and subsequent care is quite costly. Barshes et al. (2013) estimated the economic
cost of diabetic lower extremity complications at 17 billion dollars annually.
This staggering cost is comparable to the five costliest cancers in the United
State (figure 1). The development of a DFU is associated with a poor outcome,
with 5-year mortality rates as high as 50% (Braun, Fisk, Lev-Tov, Kirsner,
& Isseroff, 2014). In addition to these economic and survival costs, DFU is
associated with reduced quality of life, a higher incidence of anxiety, and
depression (Laiteerapong et al., 2011; Singh et al., 2009). These issues are
not surprising, given the impaired mobility and reduced independence associated
with DFU and amputation (Barshes et al., 2013).
DFU is preventable and treatable. The
American Diabetes Association (ADA) (2004) has issued recommendations for the
prevention of diabetic foot ulcers, including: (a) monitor
feet daily, (b) have professional
preventive care foot examinations at least annually, (c) smoking cessation to
prevent peripheral vascular disease, and (d) glycemic control to delay the
onset of peripheral neuropathy. In addition, clinicians should educate patients
regarding the importance of protective sensation and the hazards of peripheral
neuropathy, encourage patients to wear only properly fitting footwear, and
remind patients to break in new shoes gradually (ADA, 2004). What can you do to
help your patients, family, or friends with diabetes avoid this serious
complication?
Figure 1.
Annual economic cost of diabetic limb complications compared with the five most
costly cancers in the United States. Adapted from “The system of care for the
diabetic foot: objectives, outcomes, and opportunities,” by Barshes, N. R.,
Sigireddi, M., Wrobel, J. S., Mahankali, A., Robbins, J. M., Kougias, P., &
Armstrong, D. G., 2013, Diabetic Foot & Ankle, 4. Copyright 2013 Neal
Barshes et al.
References
American
Diabetes Association. (2004). Preventive foot care in diabetes. Diabetes Care,
27(1), 563-564. http://dx.doi.org/ 10.2337/diacare.27.2007.S63
Barshes,
N. R., Sigireddi, M., Wrobel, J. S., Mahankali, A., Robbins, J. M., Kougias,
P., & Armstrong, D. G. (2013). The system of care for the diabetic foot:
objectives, outcomes, and opportunities. Diabetic Foot & Ankle, 4
http://dx.doi.org/10.3402/dfa.v4i0.21847
Braun,
L., Fisk, W., Lev-Tov, H., Kirsner, R., & Isseroff, R. (2014). Diabetic foot ulcer: An evidence-based
treatment update. American Journal of
Clinical Dermatology, 15(3), 267-281.
http://dx.doi.org/ 10.1007/s40257-014-0081-9.
Laiteerapong,
N., Karter, A., Liu, J., Moffet, H., Sudore, R., Schillinger, D., & ...
Huang, E. (2011). Correlates of quality of life in older adults with diabetes:
The diabetes & aging study. Diabetes Care, 34(8), 1749-1753. http://dx.doi.org/10.2337/dc10-2424
Singh,
R., Ripley, D., Pentland, B., Todd, I., Hunter, J., Hutton, L., & Philip,
A. (2009). Depression and anxiety symptoms after lower limb amputation: The
rise and fall. Clinical Rehabilitation, 23(3), 281-286. http://dx.doi.org/10.1177/0269215508094710
No comments:
Post a Comment